Evaluating the NCCN Clinical Criteria for Recommending and Genetic Testing in Patients With Breast Cancer.

Mutations in the and genes predispose individuals to a significantly elevated risk for breast and ovarian cancers. Identification of these individuals allows for proper screening, management, and testing of at-risk relatives. NCCN has established clinical criteria for recommending testing.